Skip to main content
ELAB
NASDAQ Life Sciences

PMGC Holdings Secures $2.73M in Highly Dilutive Financing Exceeding Market Cap

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$5.2
Mkt Cap
$2.655M
52W Low
$4.62
52W High
$398.86
52W Position info
13% above low
Off High info
99% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

ELAB is trading near its 52-week low of $4.62 (13% above the low).

Summary

PMGC Holdings Inc. has entered into a Secured Pre-Paid Purchase agreement for $2.73 million in net proceeds, a sum greater than its current market capitalization, under terms that allow the investor to acquire shares at a significant discount to market price.


Key Events · Financing and Capital Events · ELAB

  • Secured Pre-Paid Purchase

    The company secured $2.73 million in net proceeds through a 'Secured Pre-Paid Purchase #2' agreement with an investor.

  • Financing Exceeds Market Cap

    The net proceeds of $2.73 million are greater than the company's current market capitalization, indicating significant financial need.

  • Highly Dilutive Terms

    The investor can purchase shares at 88% of the lowest volume-weighted average price (VWAP) over a 10-day period, which is highly dilutive to existing shareholders.

  • Harsh Financing Conditions

    The agreement includes a 120% prepayment penalty and is secured by the company's equity interests in its subsidiary, ELAB Holdings, with severe penalties for default.


Analysis · ELAB · Life Sciences

This financing arrangement is highly concerning for existing shareholders. The company is raising capital equivalent to over 100% of its current market capitalization, indicating severe financial need. The terms allow the investor to purchase shares at 88% of the lowest volume-weighted average price (VWAP) over a 10-day period, which is a deeply dilutive structure that will likely exert significant downward pressure on the stock price. Furthermore, the agreement is secured by the company's equity interests in its subsidiary, ELAB Holdings, and includes a substantial 120% prepayment penalty and harsh default clauses, highlighting the company's precarious financial position and the investor's strong protections. This type of financing often leads to substantial shareholder value erosion.

At the time of this filing, ELAB was trading at $5.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.7M. The 52-week trading range was $4.62 to $398.86. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ELAB - Latest Insights

ELAB
Jul 07, 2026, 5:18 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $1.08 info
Change: -$0.120 (-10%) info
Market Cap: $5.089M info
ELAB
Jul 06, 2026, 7:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.33
Real-time Price: $1.08 info
Change: -$0.2487 (-19%) info
Market Cap: $5.089M info
ELAB
Jul 01, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.57
Real-time Price: $1.08 info
Change: -$0.490 (-31%) info
Market Cap: $5.089M info
ELAB
Jul 01, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.28
Real-time Price: $1.08 info
Change: -$0.200 (-16%) info
Market Cap: $5.089M info
ELAB
Jun 18, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.48
Real-time Price: $1.08 info
Change: -$0.400 (-27%) info
Market Cap: $5.089M info
ELAB
Jun 08, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.56
Real-time Price: $1.08 info
Change: -$0.480 (-31%) info
Market Cap: $5.089M info
ELAB
Jun 08, 2026, 7:31 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.79
Real-time Price: $1.08 info
Change: -$0.710 (-40%) info
Market Cap: $5.089M info
ELAB
Jun 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $1.08 info
Change: -$0.440 (-29%) info
Market Cap: $5.089M info
ELAB
Jun 03, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.08 info
Change: -$0.730 (-40%) info
Market Cap: $5.089M info
ELAB
Jun 03, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.08 info
Change: -$0.730 (-40%) info
Market Cap: $5.089M info